<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>WHO classification of tumors of the ovary*</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">WHO classification of tumors of the ovary*</h1>
<div class="graphic"><div class="figure"><div class="ttl">WHO classification of tumors of the ovary*</div><div class="cntnt"><table cellspacing="0"><colgroup width="100%"></colgroup> <tbody> <tr> <td class="subtitle1_single">Epithelial tumors</td> </tr> <tr> <td class="subtitle2_single">Serous tumors</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <ul> <li>Benign <ul> <li>Serous cystadenoma </li> <li>Serous adenofibroma </li> <li>Serous surface papilloma </li> </ul> </li> <li>Borderline <ul> <li>Serous borderline tumor/atypical proliferative serous tumor </li> <li>Serous borderline tumor â€“ micropapillary variant/noninvasive low-grade serous carcinoma </li> </ul> </li> <li>Malignant <ul> <li>Low-grade serous carcinoma </li> <li>High-grade serous carcinoma </li> </ul> </li> </ul> </td> </tr> <tr> <td class="subtitle2_single">Mucinous tumors</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <ul> <li>Benign <ul> <li>Mucinous cystadenoma </li> <li>Mucinous adenofibroma </li> </ul> </li> <li>Borderline <ul> <li>Mucinous borderline tumor/atypical proliferative mucinous tumor </li> </ul> </li> <li>Malignant <ul> <li>Mucinous carcinoma </li> </ul> </li> </ul> </td> </tr> <tr> <td class="subtitle2_single">Endometrioid tumors</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <ul> <li>Benign <ul> <li>Endometriotic cyst </li> <li>Endometrioid cystadenoma </li> <li>Endometrioid adenofibroma </li> </ul> </li> <li>Borderline <ul> <li>Endometrioid borderline tumor/atypical proliferative endometrioid tumor </li> </ul> </li> <li>Malignant <ul> <li>Endometrioid carcinoma </li> </ul> </li> </ul> </td> </tr> <tr> <td class="subtitle2_single">Clear cell tumors</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <ul> <li>Benign <ul> <li>Clear cell cystadenoma </li> <li>Clear cell adenofibroma </li> </ul> </li> <li>Borderline <ul> <li>Clear cell borderline tumor/atypical proliferative clear cell tumor </li> </ul> </li> <li>Malignant <ul> <li>Clear cell carcinoma </li> </ul> </li> </ul> </td> </tr> <tr> <td class="subtitle2_single">Brenner tumors</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <ul> <li>Benign <ul> <li>Brenner tumor </li> </ul> </li> <li>Borderline <ul> <li>Borderline Brenner tumor/atypical proliferative Brenner tumor </li> </ul> </li> <li>Malignant <ul> <li>Malignant Brenner tumor </li> </ul> </li> </ul> </td> </tr> <tr> <td class="subtitle2_single">Seromucinous tumors</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <ul> <li>Benign <ul> <li>Seromucinous cystadenoma </li> <li>Seromucinous adenofibroma </li> </ul> </li> <li>Borderline <ul> <li>Seromucinous borderline tumor/atypical proliferative seromucinous tumor </li> </ul> </li> <li>Malignant <ul> <li>Seromucinous carcinoma </li> </ul> </li> </ul> </td> </tr> <tr class="divider_bottom"> <td class="subtitle2_single">Undifferentiated carcinoma</td> </tr> <tr> <td class="subtitle1_single">Mesenchymal tumors</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <ul> <li>Low-grade endometrioid stromal sarcoma </li> <li>High-grade endometrioid stromal sarcoma </li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Mixed epithelial and mesenchymal tumors</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <ul> <li>Adenosarcoma </li> <li>Carcinosarcoma </li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Sex cord-stromal tumors</td> </tr> <tr> <td class="subtitle2_single">Pure stromal tumors</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <ul> <li>Fibroma </li> <li>Cellular fibroma </li> <li>Thecoma </li> <li>Luteinized thecoma associated with sclerosing peritonitis </li> <li>Fibrosarcoma </li> <li>Sclerosing stromal tumor </li> <li>Signet-ring stromal tumor </li> <li>Microcystic stromal tumor </li> <li>Leydig cell tumor </li> <li>Steroid cell tumor </li> <li>Steroid cell tumor, malignant </li> </ul> </td> </tr> <tr> <td class="subtitle2_single">Pure sex cord tumors</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <ul> <li>Adult granulosa cell tumor </li> <li>Juvenile granulosa cell tumor </li> <li>Sertoli cell tumor </li> <li>Sex cord tumor with annular tubules </li> </ul> </td> </tr> <tr> <td class="subtitle2_single">Mixed sex cord-stromal tumors</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <ul> <li>Sertoli-Leydig cell tumor <ul> <li>Well-differentiated </li> <li>Moderately differentiated <ul> <li>With heterologous elements </li> </ul> </li> <li>Poorly differentiated <ul> <li>With heterologous elements </li> </ul> </li> <li>Retiform <ul> <li>With heterologous elements </li> </ul> </li> <li>Sex cord-stromal tumors, NOS </li> </ul> </li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Germ cell tumors</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <ul> <li>Dysgerminoma </li> <li>Yolk sac tumor </li> <li>Embryonal carcinoma </li> <li>Nongestational choriocarcinoma </li> <li>Mature teratoma </li> <li>Immature teratoma </li> <li>Mixed germ cell tumor </li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Monodermal teratoma and somatic-type tumors arising from a dermoid cyst</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <ul> <li>Struma ovarii, benign </li> <li>Struma ovarii, malignant </li> <li>Carcinoid <ul> <li>Strumal carcinoid </li> <li>Mucinous carcinoid </li> </ul> </li> <li>Neuroectodermal-type tumors </li> <li>Sebaceous tumors <ul> <li>Sebaceous adenoma </li> <li>Sebaceous carcinoma </li> </ul> </li> <li>Other rare monodermal teratomas </li> <li>Carcinomas <ul> <li>Squamous cell carcinoma </li> <li>Others </li> </ul> </li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Germ cell-sex cord-stromal tumors</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <ul> <li>Gonadoblastoma, including gonadoblastoma with malignant germ cell tumor </li> <li>Mixed germ cell-sex cord-stromal tumor, unclassified </li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Miscellaneous tumors</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <ul> <li>Tumors of rete ovarii <ul> <li>Adenoma of rete ovarii </li> <li>Adenocarcinoma of rete ovarii </li> </ul> </li> <li>Wolffian tumor </li> <li>Small cell carcinoma, hypercalcaemic type </li> <li>Small cell carcinoma, pulmonary type </li> <li>Wilms tumor </li> <li>Paraganglioma </li> <li>Solid pseudopapillary neoplasm </li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Mesothelial tumors</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <ul> <li>Adenomatoid tumor </li> <li>Mesothelioma </li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Soft tissue tumors</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <ul> <li>Myxoma </li> <li>Others </li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Tumor-like lesions</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <ul> <li>Follicle cyst </li> <li>Corpus luteum cyst </li> <li>Large solitary luteinized follicle cyst </li> <li>Hyperreactio luteinalis </li> <li>Pregnancy luteoma </li> <li>Stromal hyperplasia </li> <li>Stromal hyperthecosis </li> <li>Fibromatosis </li> <li>Massive oedema </li> <li>Leydig cell hyperplasia </li> <li>Others </li> </ul> </td> </tr> <tr> <td class="subtitle1_single">Lymphoid and myeloid tumors</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <ul> <li>Lymphomas </li> <li>Plasmacytoma </li> <li>Myeloid neoplasms </li> </ul> </td> </tr> <tr> <td class="highlight_gray_text" style="font-size: 1.2em;"><strong>Secondary tumors</strong></td> </tr> </tbody></table></div><div class="graphic_footnotes">WHO: World Health Organization; NOS: not otherwise specified.<br/>* The classification is modified from the previous WHO classification of tumors, taking into account changes in our understanding of these lesions.</div><div class="graphic_reference">Reproduced with permission from: Kurman RJ, Carcangiu ML, Herrington S, Young RH. World Health Organization Classification of Tumours of the Female Reproductive Organs. IARC, Lyon, 2014. Copyright Â© 2014.</div><div id="graphicVersion">Graphic 77703 Version 6.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
